Adam Walter‐Croneck
0000-0003-0908-0396
Publication & Citation Trends
Publications
0 total
Carfilzomib, lenalidomide, and dexamethasone compared with lenalidomide treatment after autologous haematopoietic stem-cell transplantation in patients with multiple myeloma (ATLAS): primary analysis of a randomised, open-label, phase 3 trial.
Cited by 1
Semantic Scholar
A Stepwise Screening Protocol for Multiple Myeloma OA
Cited by 1
Semantic Scholar
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial. OA
Cited by 45
Semantic Scholar
S175: ATLAS: A PHASE 3 RANDOMIZED TRIAL OF CARFILZOMIB, LENALIDOMIDE, AND DEXAMETHASONE VERSUS LENALIDOMIDE ALONE AFTER STEM-CELL TRANSPLANT FOR MULTIPLE MYELOMA OA
Cited by 1
Semantic Scholar
Antimicrobial prophylaxis in adults and children undergoing hematopoietic cell transplantation: 2021 Polish recommendations OA
Cited by 3
Semantic Scholar
Protective environment in hematopoietic cell transplantation centers: results of a survey of the Polish Federation of Bone Marrow Transplant Centers OA
Cited by 0
Semantic Scholar
Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma OA
Cited by 12
Semantic Scholar
Antimicrobial prophylaxis in patients after hematopoietic cell transplantation: results of a survey of the Polish Federation of Bone Marrow Transplant Centers OA
Cited by 7
Semantic Scholar
Research Topics
Multiple Myeloma Research and Treatments
(35)
Peptidase Inhibition and Analysis
(11)
Chronic Lymphocytic Leukemia Research
(10)
Protein Degradation and Inhibitors
(9)
Chronic Myeloid Leukemia Treatments
(8)
Affiliations
Medical University of Lublin
Instytut Medycyny Wsi im. Witolda Chodźki